Search Results for: Pharma 40 A New Initiative
Articles
Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award May 18, 2022
For the third year in a row, Vetter has won the Best Managed Companies Award. With this three-win feat, the pharmaceutical...Innoforce & Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies March 16, 2022
Innoforce and Hibiscus BioVentures recently announced they have formed a strategic partnership to leverage the combined resources of both organizations to advance new Advanced Therapy Medicinal Products (ATMPs) and biologic medicines in order to….
DNAnexus Secures $200-Million Funding to Advance its Biomedical Data-Driven Technology Platform for Precision Medicine March 8, 2022
DNAnexus, Inc. recently announced a $200-million financing round to accelerate the global adoption of its technology, translating the world’s complex...Imcyse Reports Positive Immune Response from Interim Analysis of Phase 2 IMPACT Type 1 Diabetes Study January 13, 2022
Imcyse recently reported positive biomarker data from a planned interim analysis of its Phase 2 study, IMCY-0098 Proof of ACtion in Type 1 Diabetes (T1D) (IMPACT), evaluating the company’s lead candidate….
Alcami Announces the Acquisition of Masy BioServices. December 15, 2021
Alcami Corporation recently announced it has completed the acquisition of Masy Systems Inc. (Masy or Masy BioServices), a preferred provider of cGMP Biostorage and pharma support services…..
Yumanity Therapeutics Announces Positive Top-Line Results of Phase 1b Clinical Trial for YTX-7739 in Patients With Parkinson’s Disease November 10, 2021
Yumanity Therapeutics recently reported its lead product candidate, YTX-7739, in development for the treatment of Parkinson’s disease, achieved its primary...SPECIAL FEATURE - Injection Devices: Designing Simplicity, Safety & Adherence Into One Delivery System August 26, 2021
Contributor Cindy Dubin, in this annual report, speaks with industry innovators and takes a deep dive into the myriad injectables that are currently in development or recently introduced to the market.
INJECTABLES MANUFACTURING - Manufacturing Injectable Devices: Why Modern Means Modular May 3, 2021
Raffaele Pace, MMe, MBA, reviews how today’s drug delivery devices must be more mobile, less intrusive, and simpler than ever before – all while remaining cost competitive.
EXECUTIVE INTERVIEW - Celanese: Better Therapeutic Outcomes From Better Drug Delivery March 29, 2021
Laura Brand, Vice President of Celanese’s Medical & Pharmaceutical Business, discusses her company’s drug delivery platform and the value it brings to the industry.
Relief Therapeutics & Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration & License Agreement January 28, 2021
Relief Therapeutics Holding AG and Acer Therapeutics Inc. recently announced the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license….
BIOSIMILAR DEVELOPMENT - Biosimilars: The Process & Quality System Approach to Clinical Applications January 13, 2021
Kaiser Aziz, PhD, addresses biosimilar developments and future innovations with an emphasis placed on quality system approaches to the development and availability of new biosimilar products.
Servier & X-Chem Announce Drug Discovery Collaboration January 7, 2021
Servier and X-Chem, Inc. recently announced a partnership to identify and develop novel small molecules for the treatment of….
SPECIAL FEATURE - Injection Devices: Will COVID-19 Deliver Growth to the Market? September 1, 2020
Contributor Cindy H. Dubin interviews several leading companies and highlights trends in autoinjectors, pen injectors, wearable devices and connectivity, and prefilled syringes.
Cost of Disrupted Clinical Research Due to COVID-19 Equates to $10+ Billion & Potential Study Delays July 22, 2020
What if you developed a potential cure for COVID-19, but couldn’t test the drug because of COVID-19? Thousands of researchers worldwide are facing this dilemma, as clinical studies are interrupted, altered, postponed – or even cancelled…
Catalent Announces Next Generation of Cell & Gene Therapy Leadership May 5, 2020
Catalent, Inc. recently announced the appointment of Manja Boerman, PhD, to the role of President, Cell & Gene Therapy, effective...Proveris to Present: The Effect of Ethanol Concentration on pMDI Evaporation Fraction April 9, 2020
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently...BIOSIMILAR DEVELOPMENT - Biosimilar Biological Products: Development & Applications March 2, 2020
Kaiser J. Aziz, PhD, provides an in-depth overview of biosimilar products development and the evaluation criteria for FDA approval.
Albireo Achieves Significant Milestones for Odevixibat Across Multiple Diseases January 30, 2020
Albireo Pharma, Inc. recently announced a number of advances and new initiatives in the clinical program for odevixibat, an oral once daily capsule in development for….
EXECUTIVE INTERVIEW - Cambrex: Providing Big Value in the Small Molecule Outsourcing Market October 1, 2019
Simon Edwards, President, CDMO Sales & Marketing at Cambrex, discusses the biggest trends in the small molecule outsourcing market.
Japan’s Medical Device Market Set to Reach $74.7 Billion in 2025 May 30, 2019
The Japanese medical device market is set to reach from $54.5 billion in 2018 to $74.7 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.6% says GlobalData, a leading data and analytics company.
